MoneyWorks4Me

Morepen Laboratories - Quaterly Results

02 Nov 2023 Evaluate
The revenue declined to Rs. 3812.58 millions for the quarter ended September 2023 as compared to Rs. 3833.42 millions during the corresponding quarter last year.Net profit stood at Rs. 199.24  millions  compared to Rs. 165.23 millions in the corresponding previous quarter,high by 20.58%.Operating profit surged to 325.99 millions from the corresponding previous quarter of 279.57 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 3812.58 3833.42 -0.54 7503.61 6577.39 14.08 13388.83 14492.67 -7.62
Other Income 28.38 8.74 224.71 49.22 15.83 210.93 57.59 102.35 -43.73
PBIDT 325.99 279.57 16.60 594.86 422.75 40.71 830.29 1393.72 -40.43
Interest 4.55 4.74 -4.01 7.38 8.69 -15.07 19.81 -73.66 -126.89
PBDT 321.44 274.83 16.96 587.48 414.06 41.88 810.48 1467.38 -44.77
Depreciation 48.10 44.64 7.75 97.03 88.35 9.82 180.06 211.95 -15.05
PBT 273.34 230.19 18.75 490.45 325.71 50.58 630.42 1255.43 -49.78
TAX 74.10 64.96 14.07 132.72 91.73 44.69 167.99 244.82 -31.38
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 2.03 24.83 -91.82
PAT 199.24 165.23 20.58 357.73 233.98 52.89 462.43 1010.61 -54.24
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 955.59 6.98
PBIDTM(%) 8.55 7.29 17.24 7.93 6.43 23.34 6.20 9.62 -35.51
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..